What is the difference between FDA cleared and FDA approved?

FDA clearance (via the 510(k) pathway) means a device has been demonstrated to be substantially equivalent to a legally marketed predicate device. FDA approval (via the PMA pathway) requires clinical trials demonstrating safety and effectiveness for high-risk Class III devices. Most medical devices on the market are 510(k) cleared, not FDA approved. Using 'FDA approved' when your device is 510(k) cleared is a regulatory violation that can trigger FDA enforcement action.

Can medical device companies promote off-label uses?

No. Medical device companies cannot promote their devices for uses, indications, or patient populations outside of what the FDA has cleared or approved. While surgeons can use devices off-label at their clinical discretion, the manufacturer cannot encourage, suggest, or promote those off-label uses in marketing materials, sales conversations, or any promotional context. Violations can result in warning letters, product seizure, or criminal prosecution.

Do FDA marketing rules apply to social media?

Yes. FDA regulations apply to all promotional communications, including social media platforms like LinkedIn, Instagram, YouTube, and X. Character limits and space constraints do not exempt companies from including required information such as risk disclosures, intended use statements, and accurate product claims. Companies must also monitor and manage user-generated content on their owned social channels that could be considered promotional.

What happens if a medical device company violates FDA marketing rules?

FDA enforcement actions for marketing violations range from warning letters (the most common) to product seizure, injunctions, consent decrees, and criminal prosecution. Warning letters become public record and damage company credibility. In severe cases, the FDA can order product recalls, suspend device clearances, or refer cases for criminal prosecution. Beyond direct FDA action, competitors and whistleblowers can report violations, leading to investigations.

FDA Marketing Compliance for Medical Devices

In 18 years of medical device marketing, I've reviewed thousands of pages of marketing copy, product pages, brochures, and social media posts. And I can tell you with certainty: most medical device companies are making compliance mistakes in their marketing materials right now. Some are minor. Some could trigger an FDA warning letter.

The frustrating part is that most of these mistakes are avoidable. They happen because marketing teams don't fully understand the regulatory framework, or because compliance review is treated as a bottleneck rather than an integrated part of the creative process. This guide covers the most common FDA marketing compliance mistakes I see and how to avoid them.

Why FDA Marketing Compliance Matters

The FDA regulates how medical device companies promote their products. This isn't advisory — it's enforceable law. The consequences of non-compliance range from inconvenient to devastating:

Warning letters. The most common enforcement action. Warning letters are public record, which means your customers, competitors, and investors can all see them. They require a formal response and corrective action within 15 business days.
Product seizure. The FDA can seize products that are misbranded — meaning their labeling or promotional materials contain false or misleading claims.
Injunctions. A court order that can prohibit the manufacture, distribution, or marketing of a device until compliance issues are resolved.
Consent decrees. Binding legal agreements that impose strict conditions on future marketing activities, often including third-party oversight at the company's expense.
Criminal prosecution. In serious cases, individuals responsible for violations can face criminal charges.

Beyond direct FDA enforcement, compliance failures damage credibility with the surgeons and hospital systems you're trying to sell to. A warning letter tells sophisticated healthcare buyers that you're either careless or dishonest with your product claims. Neither is a good look.

510(k) Cleared vs. FDA Approved: The Most Common Mistake

I estimate that 30-40% of medical device websites I audit use the phrase "FDA approved" incorrectly. This is the single most common compliance mistake in medical device marketing.

Here's the distinction:

510(k) Clearance: The majority of medical devices reach the market through the 510(k) pathway. This requires demonstrating that the device is "substantially equivalent" to a predicate device already legally marketed in the United States. The result is FDA clearance, not approval.
PMA (Premarket Approval): Reserved for Class III, high-risk devices like heart valves, implantable pacemakers, and certain orthopedic implants. PMA requires clinical trials demonstrating safety and effectiveness. This pathway results in FDA approval.

Writing "FDA approved" on your website when your device is 510(k) cleared is misbranding under federal law. It implies a level of regulatory scrutiny that your device has not undergone. The fix is simple: use "FDA 510(k) cleared" or simply "FDA cleared." But simple doesn't mean it's easy to catch across every page of your website, every sales deck, every trade show banner, and every social media post.

Quick Reference

510(k) pathway = FDA cleared (most devices)
PMA pathway = FDA approved (high-risk Class III devices)
De Novo pathway = FDA granted (novel low-to-moderate risk devices)
Using the wrong term is misbranding. Get it right everywhere.

Promotional vs. Educational Content

The FDA draws a critical distinction between promotional content and educational content. Understanding this distinction shapes your entire content marketing strategy.

Promotional content is intended to promote the sale or use of a specific medical device. It must include specific required information: the device's cleared indications for use, relevant risk information, and a fair balance of benefits and risks. Promotional claims must be substantiated by adequate clinical evidence.

Educational content is intended to inform healthcare professionals or the public about diseases, conditions, or treatment options without promoting a specific product. Educational content has more latitude but must still be fair, balanced, and not misleading. It cannot be disguised promotion — if the primary purpose is to drive sales of your device, it's promotional regardless of how you label it.

The gray area between these categories is where most companies get into trouble. A "clinical education" webinar that exclusively features your device and is presented by a paid KOL may be viewed by the FDA as promotional, regardless of the educational wrapper.

Off-Label Promotion: The Bright Line

Off-label promotion is perhaps the most clearly defined boundary in medical device marketing. Your device was cleared for specific indications — specific uses, specific patient populations, specific anatomical locations. You cannot promote your device for any use outside those cleared indications.

Here's where it gets nuanced:

Surgeons can use devices off-label. The FDA regulates manufacturers, not practitioners. A surgeon can use a device in any way they deem clinically appropriate. But you, the manufacturer, cannot encourage, suggest, or promote that off-label use.
Responding to unsolicited questions. If a surgeon asks about an off-label use, you can provide truthful, balanced, non-misleading information in response. But you cannot proactively initiate the conversation, and the response should direct the surgeon to the device's approved labeling.
Conference presentations. KOL presentations at medical conferences that discuss off-label uses of your device can be problematic if the company orchestrated the presentation, selected the speaker, or controlled the content. Independent scientific exchange is permissible; manufacturer-directed off-label promotion is not.
Case studies. Publishing case studies that feature off-label uses requires careful handling. The line between scientific communication and promotion depends on context, distribution, and manufacturer involvement.

Clinical Claims and Evidence Requirements

Every claim you make about your medical device must be supported by evidence appropriate to the nature of the claim. This is where disciplined marketing teams separate themselves from everyone else.

Types of Claims and Their Evidence Requirements

Safety claims require clinical data demonstrating the safety profile of your device for its cleared indications.
Efficacy claims require clinical evidence — ideally from peer-reviewed studies — demonstrating that your device performs as claimed.
Superiority claims (claiming your device is better than a competitor) require head-to-head comparative data. You cannot claim superiority based on anecdotal evidence or theoretical advantages.
Equivalence claims (claiming comparable performance to a market-leading device) are safer but still require substantiation.

On a recent project with INFAB, our regulatory review identified three distinct categories of claims in the initial marketing copy that could not be adequately substantiated with available evidence. Rather than guessing, softening the language, or hoping nobody would notice, we flagged those claims as blocked items and routed them back to the client's regulatory and clinical teams for resolution. That's the discipline this work requires — you don't fill evidence gaps with creative writing.

Comparative Advertising

Medical device companies frequently want to compare their products to competitors. The FDA allows comparative advertising, but with strict guardrails:

Comparisons must be truthful, not misleading, and substantiated by adequate evidence.
You must compare comparable products — devices with similar indications, classifications, and risk profiles.
Cherry-picking favorable data points while omitting unfavorable comparisons is misleading.
Using a competitor's name requires that the comparison be fair and not disparaging beyond what the evidence supports.

The safest approach to competitive positioning is to clearly articulate your device's strengths with supporting evidence and let surgeons draw their own comparisons. Focus on what makes your device clinically differentiated rather than what's wrong with the competition.

Social Media and FDA Compliance

Social media creates unique compliance challenges for medical device companies. The FDA has issued guidance (final and draft) on social media, and the core principle is clear: FDA regulations apply regardless of the medium.

Platform-Specific Considerations

LinkedIn: The primary platform for medical device B2B marketing. Posts about products must include risk information and stay within cleared indications. Sharing clinical data requires the same evidentiary standards as any other promotional channel.
Instagram and YouTube: Visual content featuring medical devices in clinical settings must not depict off-label uses. Video testimonials from surgeons must not include unsubstantiated claims.
Character-limited platforms: Space constraints don't exempt you from required disclosures. If you can't include necessary risk and indication information within the platform's constraints, the FDA's position is that you shouldn't make the promotional claim on that platform.

User-Generated Content

When surgeons or patients comment on your social media posts with testimonials, off-label use descriptions, or unsubstantiated claims, you have a responsibility to manage that content. While the FDA doesn't hold manufacturers responsible for truly independent third-party content, content on your owned channels creates an implied endorsement that you need to actively manage.

How We Handle Regulatory Review at Buzzbox

At Buzzbox Media, regulatory compliance is integrated into our creative process, not bolted on at the end. Here's how we approach it:

Pre-screening during content creation. We use AI-assisted workflows to flag potential regulatory issues as content is being drafted. This catches obvious problems early — like "FDA approved" misuse, missing risk disclosures, or claims that extend beyond cleared indications.
Structured claim documentation. Every clinical claim in a piece of marketing content is documented with its supporting evidence. If we can't document the evidence, the claim doesn't make it into the copy.
Deliberate blocking. When we encounter claims that need clinical or regulatory input we don't have, we block those items and route them to the appropriate team rather than making assumptions. This was our approach on the INFAB project, where three categories of claims were deliberately excluded and flagged rather than estimated.
Human regulatory review. AI pre-screening catches the mechanical issues, but nuanced regulatory judgment requires human expertise. Every piece of promotional content gets reviewed by someone who understands the regulatory framework.

This process is slower than "write it and ship it." It's also the difference between marketing that builds credibility and marketing that generates warning letters.

10 Questions to Ask Before Publishing Medical Device Marketing Content

Is every reference to FDA status accurate (cleared vs. approved vs. granted)?
Do all promotional claims stay within the device's cleared indications for use?
Is every clinical claim supported by adequate, documented evidence?
Does the content include a fair balance of benefit and risk information?
Are any claims implied that aren't explicitly stated — and are those implied claims substantiated?
Does the content avoid promoting off-label uses, even indirectly?
If comparative claims are made, are they supported by head-to-head data?
For social media content, is required disclosure information included despite space limitations?
Has the content been reviewed by someone with regulatory expertise, not just marketing approval?
Would you be comfortable if the FDA reviewed this content tomorrow?

If you answered "no" or "I'm not sure" to any of these questions, the content needs more work before publication.

Regulatory compliance in medical device marketing isn't a constraint — it's a competitive advantage. Companies that get this right build credibility with surgeons, avoid costly enforcement actions, and create marketing that actually reflects the quality of their devices. If you need help building compliant marketing programs or want to learn more about how we integrate regulatory review into creative workflows, read our guide on AI in medical device marketing or get in touch.

FDA Marketing Compliance: What Medical Device Companies Get Wrong